“…Recent studies indicate in particular that trogo‐ and phagocytosis play a pivotal role in disease manifestations and host immune evasion (Miller, Suleiman, & Ralston, 2019; Nakada‐Tsukui & Nozaki, 2020; Ralston et al, 2014; Somlata, Nakada‐Tsukui, & Nozaki, 2017). It has been shown that both amebic trogo‐ and phagocytosis are energy dependent and require Gal/GalNAc lectin, protein and lipid kinases such as C2‐domain‐containing protein kinase (EhC2PK), atypical kinase (EhAK1), and phosphoinositide‐3‐kinase (PI3K), phosphatidylinositide‐binding proteins such as FYVE domain containing protein 4 (Nakada‐Tsukui, Okada, Mitra, & Nozaki, 2009) and SNXs (Watanabe, Nakada‐Tsukui, & Nozaki, 2020), and proteins involved in actin rearrangement such as calcium binding proteins, ArpA2/3, Rho/Rac, EhP3, and EhFP10 (Agarwal et al, 2019; Babuta et al, 2020; Babuta, Kumar, Gourinath, Bhattacharya, & Bhattacharya, 2018; Babuta, Mansuri, Bhattacharya, & Bhattacharya, 2015; Bharadwaj et al, 2018; Bharadwaj, Arya, Shahid Mansuri, Bhattacharya, & Bhattacharya, 2017; Gautam, Ali, Bhattacharya, & Gourinath, 2019; Nakada‐Tsukui et al, 2009; Powell et al, 2006; Ralston et al, 2014; Somlata, Bhattacharya, & Bhattacharya, 2011; Watanabe et al, 2020). EhAGC kinase 1 represents only protein that is known to be engaged with only trogocytosis, but not phagocytosis, whereas EhAGCK2 is involved in both processes, but on the different stages of target internalisation.…”